Intracellular pharmacokinetics of gemcitabine, its deaminated metabolite 2',2'-difluorodeoxyuridine and their nucleotides.

about

Intracellular pharmacokinetics of gemcitabine, its deaminated metabolite 2',2'-difluorodeoxyuridine and their nucleotides.

Item

http://www.wikidata.org/entity/Q49929146

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Intracellular pharmacokinetics ...... uridine and their nucleotides.

@en

Intracellular pharmacokinetics ...... uridine and their nucleotides.

@nl

type

Item

label

Intracellular pharmacokinetics ...... uridine and their nucleotides.

@en

Intracellular pharmacokinetics ...... uridine and their nucleotides.

@nl

prefLabel

Intracellular pharmacokinetics ...... uridine and their nucleotides.

@en

Intracellular pharmacokinetics ...... uridine and their nucleotides.

@nl

P1476

Intracellular pharmacokinetics ...... uridine and their nucleotides.

@en

P2093

Alwin D R Huitema

http://www.w3.org/2001/XMLSchema#string

Hilde Rosing

http://www.w3.org/2001/XMLSchema#string

Jan H M Schellens

http://www.w3.org/2001/XMLSchema#string

Jos H Beijnen

http://www.w3.org/2001/XMLSchema#string

P2860

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Gemcitabine: metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer

Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2',2'-difluorodeoxycytidine

A phase I clinical, plasma, and cellular pharmacology study of gemcitabine

Human thymidine kinase 2: molecular cloning and characterisation of the enzyme activity with antiviral and cytostatic nucleoside substrates

Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients.

Pharmacologically directed design of the dose rate and schedule of 2',2'-difluorodeoxycytidine (Gemcitabine) administration in leukemia.

A phase I study of gemcitabine and carboplatin in non-small cell lung cancer.

Recent molecular advances in studies of the concentrative Na+-dependent nucleoside transporter (CNT) family: identification and characterization of novel human and mouse proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosi

Cellular pharmacology of gemcitabine.

P304

1279-1289

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BCP.13557

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ellen J B Derissen

P577

2018-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29451684

http://www.w3.org/2001/XMLSchema#string

P932

5980516

http://www.w3.org/2001/XMLSchema#string